Detalhe da pesquisa
1.
Cannabidiol modulates contextual fear memory consolidation in animals with experimentally induced type-1 diabetes mellitus.
Acta Neuropsychiatr
; : 1-11, 2023 Feb 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36805056
2.
Early evidence of beneficial and protective effects of Protectin DX treatment on behavior responses and type-1 diabetes mellitus related-parameters: A non-clinical approach.
Prog Neuropsychopharmacol Biol Psychiatry
; 133: 111028, 2024 Jul 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38754696
3.
Long-term treatment with roflumilast improves learning of fear extinction memory and anxiety-like response in a type-1 diabetes mellitus animal model.
Behav Brain Res
; 439: 114217, 2023 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36400237
4.
Resolvin D5 disrupts anxious- and depressive-like behaviors in a type 1 diabetes mellitus animal model.
Naunyn Schmiedebergs Arch Pharmacol
; 395(10): 1269-1282, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35852551
5.
Fish-oil supplementation decreases Indoleamine-2,3-Dioxygenase expression and increases hippocampal serotonin levels in the LPS depression model.
Behav Brain Res
; 390: 112675, 2020 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32407816
6.
Activation of mineralocorticoid receptors facilitate the acquisition of fear memory extinction and impair the generalization of fear memory in diabetic animals.
Psychopharmacology (Berl)
; 237(2): 529-542, 2020 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-31713655
7.
Sub-chronic treatment with cannabidiol but not with URB597 induced a mild antidepressant-like effect in diabetic rats.
Neurosci Lett
; 682: 62-68, 2018 08 24.
Artigo
Inglês
| MEDLINE | ID: mdl-29885450